The latest news about Lumendi

DiLumen EIP is now even easier to use with EZ-Glide hydrophilic coating

DiLumen EZ-Glide improves visibility and simplifies intraoperative

Thank you to Prof. Peter Bauerfeind and Dr. Hugo Uchima

Thank you to Prof. Peter Bauerfeind and Dr. Hugo Uchima for a great workshop in Lucerne. The international group of endoscopists enjoyed the educational value and the practical experience of… Continue reading Thank you to Prof. Peter Bauerfeind and Dr. Hugo Uchima

Thank you for supporting our Patient Awareness Initiative

Thank you for supporting our Patient Awareness Initiative

EZ Glide Pushes Lumendi to New Quarter-Over-Quarter Sales Record

DiLumen® Product Enhancement Launched in December 2020 on Track to Double Sales from Previous Year September 28, 2021 WESTPORT, Conn.--(BUSINESS WIRE)-- EZ Glide, the most recent enhancement to Lumendi’s DiLumen Endoluminal Interventional… Continue reading EZ Glide Pushes Lumendi to New Quarter-Over-Quarter Sales Record

Introducing Lumendi’s latest Innovation in Asia

Innovative Surgical Platform Improves the Safety and Speed of Endolumenal Procedures For patients with complex benign colorectal polyps, surgical intervention tends to be the norm. Yet, endoluminal procedures like endoscopic… Continue reading Introducing Lumendi’s latest Innovation in Asia

Lumendi Introduces EZ Glide Hydrophilic Coating for Its DiLumen Endoluminal Interventional Platform (EIP™)

Lumendi Platforms to be Discussed in Investor’s Webcast 31 March 2021 with Panel of Clinical Experts New EZ Glide, activated by water or saline, improves endoscopic performance of the DiLumen… Continue reading Lumendi Introduces EZ Glide Hydrophilic Coating for Its DiLumen Endoluminal Interventional Platform (EIP™)

The Cost-Effectiveness of DiLumenTM for Endoscopic Intervention of Complex Colonic Polyps

The Cost-Effectiveness of DiLumenTM  for Endoscopic Intervention of Complex Colonic Polyps
James White, D.O., VP of Medical Affairs, Lumendi
Karl Florence, Reimbursement Consultant.

LUMENDI RECEIVES 510(k) CLEARANCE FOR DILUMEN Ik™ ENDOLUMENAL INTERVENTIONAL KNIFE

1000 Therapeutic Procedures Using DiLumen™ EIP Completed Across U.S., Europe and Asia WESTPORT, CONN, August 20, 2019 − Connecticut-based medical device innovator Lumendi, LLC (http://www.lumendi.com) has announced it has received U.S.… Continue reading LUMENDI RECEIVES 510(k) CLEARANCE FOR DILUMEN Ik™ ENDOLUMENAL INTERVENTIONAL KNIFE

A new platform to facilitate exposure of difficult-to-access lesions has been designed

As seen on Endoscopic submucosal dissection of a laterally spreading tumor in the right colon with a gastroscope after shortening the colon using a new double-balloon platform Endoscopic submucosal dissection… Continue reading A new platform to facilitate exposure of difficult-to-access lesions has been designed

LUMENDI BRANDS EXCLUSIVE TISSUE MANIPULATION FEATURE FOR COMPANY’S DILUMEN EIP

DiLumen +DR Dynamic Retraction System Improves Endoscopists’ Ability to Dissect and Ultimately Resect Polyps Without Surgical Intervention WESTPORT, CONN, June 11, 2019 — Connecticut-based medical device innovator Lumendi, LLC has launched… Continue reading LUMENDI BRANDS EXCLUSIVE TISSUE MANIPULATION FEATURE FOR COMPANY’S DILUMEN EIP

LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN C2TM

Second Generation Endoscopic Accessory for Endolumenal Procedures WESTPORT, CONN, April 23, 2018 – Connecticut-based medical device innovator Lumendi, LLC has announced it has received United States Food and Drug Administration… Continue reading LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN C2TM

LUMENDI EXPANDS TEAM WITH NEW VP OF SALES, MICHAEL R. THOMAS

WESTPORT, CT, August 21, 2018 – Connecticut-based medical device innovator Lumendi, LLC is again expanding its team as Michael R. Thomas joins as Vice President of Sales. Mr. Thomas is… Continue reading LUMENDI EXPANDS TEAM WITH NEW VP OF SALES, MICHAEL R. THOMAS

LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN Is ENDOLUMENAL INTERVENTIONAL SCISSORS

Second Generation Endoscopic Accessory for Endolumenal Procedures WESTPORT, CONN, May 29, 2018 − Connecticut-based medical device innovator Lumendi, LLC has announced it has received United States Food and Drug Administration… Continue reading LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN Is ENDOLUMENAL INTERVENTIONAL SCISSORS

LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN C2TM

Second Generation Endoscopic Accessory for Endolumenal Procedures WESTPORT, CONN, April 23, 2018 – Connecticut-based medical device innovator Lumendi, LLC has announced it has received United States Food and Drug Administration… Continue reading LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN C2TM

Lumendi to Present at Digital Medicine & Medtech Showcase

  Lumendi to Present at Digital Medicine & Medtech Showcase WESTPORT, CONN, November 10, 2017 – Lumendi Ltd., a privately held innovative medical device company, announced today that Chief Executive Officer… Continue reading Lumendi to Present at Digital Medicine & Medtech Showcase

Stabilizing The Scope: How The DiLumen EIP Changes Intestinal Surgery

Stabilizing The Scope: How The DiLumen EIP Changes Intestinal Surgery Daniel Seeger Editor with www.surgicalproductsmag.com Surgeons interested in expanding their alternatives in pursuing minimally invasive options need to be attuned to… Continue reading Stabilizing The Scope: How The DiLumen EIP Changes Intestinal Surgery

DILUMEN™ EIP COMPLETES 100 THERAPEUTIC PROCEDURES ACROSS UNITED STATES

DILUMEN™ EIP COMPLETES 100 THERAPEUTIC PROCEDURES ACROSS UNITED STATES WESTPORT, CONN, DECEMBER 6, 2017 − Connecticut-based medical device innovator Lumendi, LLC reports it has successfully completed more than 100 therapeutic procedures… Continue reading DILUMEN™ EIP COMPLETES 100 THERAPEUTIC PROCEDURES ACROSS UNITED STATES

LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS

LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS Primary Study Endpoint Reached with no Serious Adverse Events WESTPORT, CONNECTICUT, November 16, 2017 – Connecticut-based medical device innovator Lumendi, LLC… Continue reading LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS

LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S.

LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S. Lumendi Submits Premarket Notification to US FDA For DiLumen C2™ and the DiLumen Is™ as Part… Continue reading LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S.

LUMENDI EXPANDS MEDICAL ADVISORY BOARD WITH THREE GLOBAL EXPERTS IN ADVANCED ENDOSCOPY

LUMENDI EXPANDS MEDICAL ADVISORY BOARD WITH THREE GLOBAL EXPERTS IN ADVANCED ENDOSCOPY Dr. Sergey V. Kantsevoy, Professor Alessandro Repici and Professor Kazuki Sumiyama to help guide improvements in endoscopic interventions… Continue reading LUMENDI EXPANDS MEDICAL ADVISORY BOARD WITH THREE GLOBAL EXPERTS IN ADVANCED ENDOSCOPY

DDW 2016 Workshop: DiLumen

Jeff Milson explains the new technique for endolumenal surgery during a panel alongside the Digestive Disease Week 2016 in San Diego Summary. Lumendi staff and clinical advisory board were attending… Continue reading DDW 2016 Workshop: DiLumen

William Wick: CFO of Lumendi LLC

Today we introduce to you another member of Lumendi’s Management Team, Michael Wick. Mr. Wick has served as Chief Financial Officer of Vivaldi Biosciences Inc. since 2007 and also was appointed… Continue reading William Wick: CFO of Lumendi LLC